Nanoview Biosciences
Developing proprietary products that support research, translation and delivery of precision medicine.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Oct 2018.)
Boston Massachusetts (HQ & founding location)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Grant | ||
$450k | Grant | ||
N/A | Series A | ||
* | $10.0m | Series B | |
$6.0m | Series B | ||
* | $200k | Grant | |
* | N/A | $2.5m | Debt |
* | N/A | Acquisition | |
Total Funding | €15.1m |
Recent News about Nanoview Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.